TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.08B
AUM Growth
+$3.08B
(+5.9%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
31.64%
Holding
198
New
2
Increased
42
Reduced
40
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$41.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$22.5M |
| 3 |
United Therapeutics
UTHR
|
$13.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.4M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.7M |
Top Sells
| 1 |
Elevance Health
ELV
|
$21.8M |
| 2 |
Illumina
ILMN
|
$21.3M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
Waters Corp
WAT
|
$18.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
$15.8M |
Sector Composition
| 1 | Healthcare | 95.67% |
| 2 | Real Estate | 2.94% |
| 3 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sutro Biopharma
STRO
$85.6M
| $7.44M | 0.24% |
400,147
-173,676
| -30% | -$3.23M |
|
|
LTC
102
LTC Properties
LTC
$1.67B
| $7M | 0.23% |
182,293
| – | – |
|
103
uniQure
QURE
$954M
| $6.96M | 0.23% |
225,921
+100,918
| +81% | +$3.11M |
|
104
Y-mAbs Therapeutics
YMAB
$390M
| $6.69M | 0.22% |
197,820
| – | – |
|
105
Zai Lab
ZLAB
$3.48B
| $6.64M | 0.22% |
37,523
| – | – |
|
106
Arvinas
ARVN
$580M
| $6.62M | 0.22% |
85,997
| – | – |
|
|
SAGE
107
DELISTED
Sage Therapeutics
SAGE
| $6.48M | 0.21% |
114,119
| – | – |
|
108
Fate Therapeutics
FATE
$115M
| $6.31M | 0.21% |
72,727
-77,616
| -52% | -$6.74M |
|
109
Align Technology
ALGN
$9.59B
| $6.06M | 0.2% |
9,925
| – | – |
|
110
Teva Pharmaceuticals
TEVA
$21.5B
| $6.02M | 0.2% |
607,651
-52,900
| -8% | -$524K |
|
111
Amicus Therapeutics
FOLD
$2.42B
| $5.99M | 0.19% |
621,659
| – | – |
|
112
Revvity
RVTY
$9.68B
| $5.73M | 0.19% |
37,094
| – | – |
|
|
113
Steris
STE
$23.9B
| $5.71M | 0.19% |
27,655
-99,124
| -78% | -$20.4M |
|
114
Kura Oncology
KURA
$732M
| $5.7M | 0.19% |
273,463
| – | – |
|
|
RETA
115
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.41M | 0.18% |
38,219
| – | – |
|
116
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.16M | 0.17% |
397,920
| – | – |
|
|
TRIL
117
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.13M | 0.17% |
529,226
| – | – |
|
118
Healthpeak Properties
DOC
$12.3B
| $5.01M | 0.16% |
150,392
| – | – |
|
|
VRNA
119
Verona Pharma
VRNA
$9.18B
| $4.92M | 0.16% |
751,905
| – | – |
|
120
Centene
CNC
$14.8B
| $4.91M | 0.16% |
67,290
| – | – |
|
121
Addus HomeCare
ADUS
$2.08B
| $4.73M | 0.15% |
54,237
+16,597
| +44% | +$1.45M |
|
122
Smith & Nephew
SNN
$16.2B
| $4.68M | 0.15% |
107,670
+8,110
| +8% | +$352K |
|
123
Personalis
PSNL
$430M
| $4.55M | 0.15% |
179,731
| – | – |
|
|
RCM
124
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.5M | 0.15% |
202,351
+78,890
| +64% | +$1.75M |
|
125
Cogent Biosciences
COGT
$1.83B
| $4.36M | 0.14% |
537,742
| – | – |
|